Thousand Oaks, CA, United States of America

Daxian Shan

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Amgen Inc.. Active years: 2001-2005.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 172(Granted Patents)


Company Filing History:


Years Active: 2001-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Daxian Shan: Innovator in Biologically Active Agent Delivery Systems

Introduction

Daxian Shan is a notable inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of biologically active agent delivery systems. With a total of 2 patents, his work focuses on innovative methods for sustained release of proteins.

Latest Patents

Daxian Shan's latest patents include the development of polyol/oil suspensions for the sustained release of proteins. The first patent describes the preparation of polyol/thickened oil suspensions containing a biologically active agent, aimed at achieving sustained delivery. The protein/glycerol/oil suspensions he developed demonstrate a sustained release of proteins, such as G-CSF, for up to at least one week. The second patent mirrors this innovation, emphasizing the same preparation methods and sustained release capabilities.

Career Highlights

Daxian Shan is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to explore and develop advanced delivery systems for biologically active agents. His innovative approaches have the potential to significantly impact therapeutic applications.

Collaborations

Daxian has collaborated with esteemed colleagues, including Merrill Seymour Goldenberg and Alice C Beekman. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Daxian Shan's contributions to the field of biologically active agent delivery systems highlight his role as an influential inventor. His patents reflect a commitment to advancing medical technology and improving patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…